TheEuropeanAssociationfortheStudyofObesity(EASO)
wasfoundedin1986withtheaims'topromoteresearchinto obesity, facilitate contact between individuals and organisations,andpromoteactionthattacklestheepidemicofobesity'.Aftertwoandhalfdecadesofexistence,EASOhassubstantially expanded its activities and at the time of writing, EASOcomprisesnationalobesityassociationsin40member states(seewww.easoobesity.org).Inparallel,thepotentialfor obesity research in Europe has significantly increased, as shown by past and ongoing large-scale EU-funded research projectsinthefieldofobesityandrelatedtopics.
Inordertobetterunderstandthisextensiveandculturally diversecommunityofpartners,EASOwishedtogetabetter understandingofongoingactivitiesrelatedtoobesityresearch andmanagementofresearchinEurope.Oneimmediateneed was to be informed about the need for research in various regions, the capacity of the European research community, andtheimpactofresearchonthesocial,psychological,economic and medical issues associated with the obesity epidemic.Theinitialstepwastoconveneameetingofexpertsto provideasnap-shotreviewofthecurrentstatusandeffectiveness of obesity research in Europe. This group was termed EASOScientificAdvisoryBoard(SAB)andwaschairedby JohnBlundell.Theexpertsweregivenaseriesofquestionsto direct their thinking towards specific problems and issues. TheSABmetfora1-daymeetingonJanuary16,2010atthe Department of Nutrition, Pitié-Salpêtrière Hospital in Paris underthepatronageofJean-MichelOppert,thePresidentof EASO.InordertofurnishtheSABwithafullpictureofthe landscapeofresearch,questionnairesweresenttothepresidents of every national obesity association in each member state (n = 40), and also to the chairpersons of each of the EASO Task Forces (TF): Childhood Obesity TF -Ram Weiss;ObesityManagementTF-ConstantineTsigos;Public HealthandPreventionTF-TommyVisscher.Theresponses tothesequestionnaireshelpedtoguidethediscussionofthe SAB.
The invited members of the SAB were: Carlos Dieguez (Spain),JohannesHebebrand(Germany),DominiqueLangin (France), Nick Finer (UK), Jean-Michel Oppert (France), Thorkild I.A. Sørensen (Denmark), and Jane Wardle (UK). Thesemembersrepresentedawidecross-sectionofresearch in obesity, ranging from adipose tissue biology to neurosciencethroughgenetics,behaviouralsciences,epidemiology and public health as well as clinical management of obesity, althoughthecoveragewasnotexhaustive.Thisbriefsynopsis istoprovideanoverviewofthemajorissuesdiscussedwithin theSAB.
Although it is known that approximately 1-5% of obese children and 1% of obese adults harbour mutations in the melanocortin-4 receptor gene (MC4R), it is assumed that 'normal' obesity is a polygenic condition. The advent of genomewideassociationstudies(GWAS)andtheuseoflarge samples for the first time allowed the large-scale detection andvalidationofgenevariants,thusrepresentingamajorstep forward.However,despiteasubstantialinvestment(financial and intellectual) into the genetics of obesity, the results are disappointinginthatonlyasmallfractionofthevarianceof theBMI(kg/m 2 )canbeexplained.Meta-analysesofGWAS haverevealedthatapproximately30obesitypolygenesinflu-enceBMI;theeffectsizesofthesepolygenesare(very)small. ThefunctionallyrelevantvariationattheDNAlevelneedsto be determined for all of the respective association signals. ThenotionthattheCNSisimportantinthedevelopmentof obesity is supported by the fact that most of the respective genes are expressed centrally. The heritability of obesity is estimatedbetween40and70%,butthecurrentlyknownpolygenes do not provide a basis for the prediction of who will becomeobese.Predictionissubstantiallybetterifbasedonan evaluation of the weight status of parents and siblings. Ten years ago confidence was high that genetics would provide insightsintothecauses,mechanisms,andsolutionsforobesity. In the light of the current outcomes, the SAB discussed thefutureforobesitygenetics.Doweneedanongoingdebate concerningthedirectionofgeneticresearchandthefinancial investmenttobecommitted?Whatisthepartofepigenetics andother'omics'inthisfield?ShouldEASOhavearolein thatdebate?
Inthecloselyrelatedareaofadiposetissuebiochemistry, thekeyareasofinterestare:howdoesadiposetissuedevelop (adipogenesis)andhowdoesitleadtopathology?Thereappearstobeamismatchbetweentheanimal(mainlyrodents) andhumanresearchsinceusuallyinanimalsadiposetissueis studiedduringgrowth(onahigh-fatdiet)andinhumansafter growth(onceapersonhasbecomeobese).Thismaybelogistically inevitable but it questions whether or not animal research is truly throwing light on human processes. Specifically,itcanbeasked:whataretheimplicationsforhumansof studies on inflammation in animals? The situation is clearly complex, not least because of the different cell types in adipose tissue and the extent to which each of these cell types playsaroleinleadingtoimpairmentinmuscleorliver.
However,thereappearstobearevivalofinterestinbrown adipose tissue (BAT) following little interest over 15 years. Why should this be? Interest in BAT declined after it transpiredthattheb3receptorwasfunctionalinmouse,butlessso inhumanadiposetissue.Itremainstobeseenhowthescientificcommunitywillreactto-andabsorb-thenewfindings onBAT.Atthisstageintheprogressofresearch,wecanask: how does adipose tissue research really inform us about the aetiologyofobesity,andhowcanresearchoutcomesbetranslatedintousefulclinicalpractice?Aretheregoodexamplesof researchinthisareahelpingtounderstandthemedicalcomplicationsproducedasaresultofaccumulatingfatinthebody? Similarquestionscanbeaskedoftherelationshipbetween neuroscience research and obesity. The neural networks and matrices of receptor interactions have been quite well constructed within the framework of 'energy homeostasis'. Considerableadvanceshavebeenmadeinthelast15yearsstimu-latedbythediscoveryofleptin,and,withinthehypothalamus, neuropeptide Y (NPY), agouti-related peptide (AgRP), melanocyte-stimulating hormones (MCH), Pro-opiomelanocortin (POMC) and orexins provide a basis for describing pathways for weight gain and loss. The link between peripheral peptides such as ghrelin, Peptide YY (PYY), glucagonlikepeptide-1(GLP-1)andreceptorsinthebrainhasfurther articulated the mechanisms underlying the control of energy intake. Opioids and the endocannabinoids are usually subscribed under a related hedonic system. These systems, togetherwiththepreviouslyknownbiogenicaminesprovideda neuralexplanationforthemechanismofactionofantiobesity drugs such as sibutramine (re-uptake inhibitor of serotonin (5-HT)andnorepinephrine(NE))andrimonabantandtaranabant(CB1-Rinverseagonists),andforthepossibledevelopmentoffuturedrugsbasedonY2andY4receptors,MCHantagonists and others. However, the failure of CNS drugs to produceafavourablerisk-benefitratiohasleadtotheprohibition of the CB1-R inverse agonists and the removal of approvalforsibutramineinEurope(andpossiblyintheUSAin thenearfuture).Theproblemisthattheweightlossachieved bymostdrugsisintheorderof3.5-6.0kg/year-whichisvery modest.Whensetagainstanincreasedriskofcardiovascular andpsychiatricadverseevents,theadvantagesseemtrivial,although there may well be some additional beneficial effects withsomeofthesedrugsindependentlyoftheweightloss(e.g. improvementinlipidprofile,insulinresistance,etc).
Currently, there is considerable interest in developing pharmacotherapy using combinations of drugs, including topirimate/phentermine, naltrexone/bupropion, naltrexone/ zonisimide, amylin/metroleptin and others. The extent to whichthesedrugscanproduceamoresatisfactoryrisk-benefitratioremainstobedemonstrated;theycertainlyhavethe potentialtoproduceagreaterweightloss.Atthepresenttime neither the Food and Drug Administration (FDA) nor the EuropeanMedicinesAgency(EMEA)haveyetissuedanapprovalforanyofthesecombinations.Whilstitcanbeclaimed thatCNSresearchhascontributedatheoreticalrationalefor thedevelopmentofdrugsthathaveappearedinthelastdecade,thequestionstillremainswhetherornotbrainresearch canprovideatherapeuticsolutiontotheproblemofobesity.
Onetechnologicaladvancethatshouldbementionedisthe use of functional magnetic resonance imaging (fMRI) scanningtothrowlightonbrainmechanismsresponsibleforappetitecontrolorweightregulation.Thisissueiscurrentlygeneratingwidespreadinterest.However,althoughtheprocedure canilluminatesomeofthehedonicandhomeostaticcontrols over eating behaviour, the resolving power is not very high and fMRI may be a tool that allows description rather than explanation. Nevertheless, this procedure is sure to be implicated in the development of novel classes of anti-obesity drugs. Theissueofpharmacologicaltreatmentdrawsattentionto thesuccessofothermanagementprocedures.Atpresenttime theuseofbehaviouralandnutritionalstrategiesandtargeted lifestylestrategiesofferadegreeofweightlossapproximately doublethatprovidedbydrugs.Neitherapproachmeetstheexpectationsofmostpatients,andbothrelyondegreesof patient compliance that are rarely maintained. What does research tells us about ways to strengthen compliance or to prevent non-compliance?Moreover,thereisaquestionofwhentointervene?Intheearlyphaseofweightgain(anoverweightperiod), or only after frank obesity has developed? This raises thekeyissueofpreventionversustreatmentandposesquestionsforthetacticsofpopulationmanagementofobesityfrom a public health perspective. Is this a question that can be solvedbyresearchorratherbysocio-economicanalysis? WhatistheValueofObesityResearch? 281 ing. However, research is needed into ways to empower people to engage in physical activity, and in constructing an environment(physicalandsocio-cultural)thatenablespeople tomakethehealthychoicesandpreventspeoplefrombeing lured into unhealthy behavioural patterns. The goal for currentandfutureresearchisclear. Withthefocusonthebehaviouralunderpinningsofobesity -andespeciallypaediatricobesity-,epidemiologicalresearch is strong although the sensitivity of measures used in large populationstudiescanalwaysbeimproved.Paediatricobesity isstronglyheritable,butthecurrentmoleculargeneticanalysescannotexplaintheheritability.Whereasthechartingand recording of paediatric obesity is adequate (and has illustrated the scale of the problem), instigating behavioural change is extremely difficult. Concerning behavioural interventions,socialcognitivemodelshavebeenusefulindescribingtheprocessesthatleadtochange,butfarlesseffectivein actually producing change. Deliberate (volitional) control overpersonalbehaviour(eatingandexercise)isverydifficult toachieveforthosewhoneeditmost(whoareprobablypredisposedtogainweight).Researchhastakenussofartheoretically but has failed to deliver the mechanisms for implementingchange.Isitrealistictoexpectthis?Perhapsbehaviour change requires the political will rather than more research?Canresearchdeliverabehaviourbreakthrough?
However, there is still a serious lack of understanding of the importance of behaviour (in comparison with genetics, biology,andnutrition)andhowtomanageitatthepopulationlevel.Theremayalsobesomeapprehensionaboutfailing tounderstandbehaviouritself.Attheindividuallevel,clinical psychologyhasdevelopedeffectiveprocedurestobringabout changesinbehaviourandassociatedcognitions. Towhatextenthasresearchonappetiteandfoodintake behaviour really helped in understanding the problems of obesepeople?Researchhasdemonstratedthecomplexityof processescontrollingappetiteandindicatedthatbehaviour, andsensations,canbegeneratedbytheenvironmentaswell asbybiology.Indeedtheimpactofthe'obesogenic'environment is mediated through explicit and implicit effects on cognitions and behaviour. Research has also identified behaviouralcomponentsofthesusceptiblephenotypeandhas provided a taxonomy for discussing vulnerability to weight gain. However, articulating a description of this situation is not the same thing as building a management strategy (as has been noted for other domains of research). Indeed a certainamountofappetite-relatedresearchactuallyservesto support the food industry component of the obesogenic environment. Takingabroadoverviewitcanbeperceivedthatscientific research has advanced markedly since the first European CongressonObesity(ECO)inStockholmin1987-almosta quarter of a century ago. There has been a proliferation of books, journals, congresses and symposia, scientific articles, andpressreleasesofbreakthroughsonaregularbasis.Indeed In this discussion, the role of bariatric surgery acquires considerableprominence.Thesuccessoftheprocedures(particularly gastric bypass) in achieving weight loss is beyond dispute; however there are risks, including death. It is paradoxicalthatsurgicalprocedurescanbecarriedoutwithouta precedingclinicaltrialandwithout,apparently,theneedfor considerationbyastatuary(orlicensing)bodyofthepossibilityofrisks.Fromascientificperspective,bariatricprocedures arefascinatingsincetheyarebeginningtothrowfurtherlight on the role of gastrointestinal peptides in the therapeutic response, and therefore (although less convincingly) in the overallcontrolofhomeostasis.Whatisthefutureofbariatric surgery?Aretherestillmoresophisticatedproceduresyetto bedeveloped?Andwhatpercentageoftheobesecommunity shouldbetreatedthroughsurgery?
One major question for EASO is how to evaluate the effectiveness(economic,social,psychologicalandmedical)of the various modalities of managing obesity, and where researchinvestmentshouldbefocussed.
Considering the role of physical activity for obesity, the currentpositionisthatincreasingphysicalactivityisessential forthepreventionofweightgainandthatitmakesameasurablecontributiontoweightloss.However,itshouldbenoted that the scientific community is quite divided in its opinions about the role of exercise in weight loss. Do we need more researchtoresolvethisissue,orisitaquestionofanalysisand debate? One dilemma is that the amount (dose) of exercise required to make a serious impact on body weight is perceivedtobeunrealisticallyhighandthereforeunachievable; ontheotherhandanamountofphysicalactivitythatwould betolerable(andevenenjoyable)wouldhardlybeeffective. Also, there are issues concerning the accuracy of measurement of physical activity under free-living conditions. Questionnairesarenotveryprecise,andmovementsensorscanbe unreliableandrelativelyinsensitivetosometypesofactivity. Hasresearchreallyinformedusaccuratelyenoughaboutthe amountofphysicalactivitythatpeopleareactuallyperforming?Wecanbesurethatitisnotenough.Onestepforward wouldbeanimprovementinthetechnologyofinstrumentation. Regarding wider environmental issues, the problem is the way in which the environment is structured to favour sedentariness.Reducingtheamountofsedentarybehaviouris recognized as different from increasing physical activity and possiblyamoreachievableobjective.Forchildren(andsometimes for adults) there is often a conflict between priorities; for example in the trade off between safety and adventure (risk).Environmentsperceivedasdangerousarenotconducivetothepromotionofoutdoorphysicalactivity.Consideringbiologicalbenefits,thereisincreasinginterestinadevelopmentalroleforphysicalactivityinimprovingmentalfunctioningandstrengtheningtheimmunesystem.Thesebenefits canoccurseparatelyfromanyeffectonbodyweight.Inthis domain, the advantages of increasing physical activity and decreasingsedentarinessarenotindoubt;researchisconvinc-Isthisthetimeforaseriousreconsiderationofthevalueof obesityresearch?Howmuchmoreknowledgeisneededand inwhichareas?Shouldonlytranslationalresearchbefunded? TheSABofEASOhasbegunaprocessofexaminationofthe truevalueofresearchinourfieldofinterest.Thissynopsisis onlyapartialreflectionofwhathasbeendiscussed.Inturn, whathasbeendiscussedisnotacompleterepresentationof the entire spectrum of research. Many areas have not been covered, but deserve to be examined in the near future. It maytakeashortwhiletomakeacomprehensivereviewofall aspectsofresearch,butitistheambitionofEASOtoinvigorateourthinking,tostimulatereflection,andtoinitiateacontinuous dialogue with its members on these crucial issues. This process will be continued as part of EASO work programmerelyingonEASOSAB-andwillbecarriedonduringournextcongressesinIstanbul(2011),Lyon(2012),and Liverpool(2013).
there have been breakthroughs but what has been their impactontheunderstandingoftheaetiologyandmanagement ofobesity?Duringa25-yearperiodofimmenseresearchactivity,theobesityepidemichascontinuedtogrow,suggesting that research is not providing the information or the knowhowtosuppressthecausesofpopulationweightgain.Indeed, itmaybequestionedthat,despitetheaccumulationofknowledgeandfacts,thecauseofthe'epidemic'remainelusive.It hasbeenproposedthatthecomfortingenergybalancemodel may not be capable of explaining secular changes in body weightduringcrucialperiodsofincreaseinobesityduringthe last50years.Isitpossiblethenthatwestilldonotreallyunderstandwhat'causes'obesity?Perhapsresearchisaseparate undertakingthatcanexistinparalleltoanongoingepidemic, anddrawingjustification(andfunding)fromthegrowingsocial and economic burden. What are the implications of this forplanningourfutureresearchstrategy?
